Tag: FWB:6BX

February 5, 2020

Relevium Announces Update Call for Shareholders

Relevium is pleased to announce a shareholder information video-conference call to provide an update on the current business and ongoing...
January 28, 2020

Relevium Provides Update on Newscope Transaction

Relevium Technologies Inc. is pleased to provide an update on the proposed transaction with Newscope Capital.
December 19, 2019

Relevium’s CEO Provides an Open Shareholder Letter for 2020

Relevium Technologies Inc. is pleased to provide an open letter to its shareholders from the company’s Chief Executive Officer, Aurelio...
November 20, 2019

Relevium Launches LeefyLyfe™ Organic Hemp Products in the US

Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF) is pleased to announce the launch of LeefyLyfeTM Organics.
November 8, 2019

Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company

Relevium Technologies Inc. announces it has executed an LOI to acquire a biopharma contract manufacturing company.
November 7, 2019

Relevium Technologies Appoints Mark Billings as Chief Financial Officer

Relevium Technologies is pleased to announce the appointment of Mark Billings, CFA as Chief Financial Officer for both Relevium and...
October 30, 2019

Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East

Relevium Technologies Inc. is pleased to announce that its wholly owned subsidiary, BGX E-Health LLC, has received a purchase order.